| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 03/14/2001 | EP1082962A1 UTILIZATION OF 2-HYDROXY-4-TRIFLUOROMETHYLBENZO C ACID DERIVATIVES AS INHIBITORS OF THE ACTIVATION OF THE NUCLEAR TRANSCRIPTION FACTORS NF-$g(k)B |
| 03/14/2001 | EP1082960A2 Use of CRF antagonists and related compositions for treating depression and modifying the circadian rhytm |
| 03/14/2001 | EP1082959A1 NK1 Antagonists for the treatment of depression |
| 03/14/2001 | EP1082456A1 Antisense modulation of cd40 expression |
| 03/14/2001 | EP1082433A1 Interleukins-21 and 22 |
| 03/14/2001 | EP1082431A2 Protease inhibitor peptides |
| 03/14/2001 | EP1082426A2 Human socs proteins |
| 03/14/2001 | EP1082422A2 Polypeptides from creb binding protein and related protein p300 for use in transcriptional regulation |
| 03/14/2001 | EP1082421A2 Human bmp-2 promoter and method for exploring bone-related substance by using the same |
| 03/14/2001 | EP1082419A2 Combination therapy using nucleic acids and conventional drugs |
| 03/14/2001 | EP1082416A2 Poly(adp-ribose)polymerase gene |
| 03/14/2001 | EP1082415A1 Methods and compositions useful for modulation of angiogenesis using tyrosine kinase src |
| 03/14/2001 | EP1082345A1 Method of designing agonists and antagonists to egf receptor family |
| 03/14/2001 | EP1082344A2 Glycoproteins having lipid mobilising properties and therapeutic applications thereof |
| 03/14/2001 | EP1082338A1 17 beta-nitro-11 beta-arylsteroids and their derivatives having agonist or antagonist hormonal properties |
| 03/14/2001 | EP1082337A1 17 beta-amino and hydroxylamino-11 beta-arylsteroids and their derivatives having agonist or antagonist hormonal properties |
| 03/14/2001 | EP1082336A2 Apoptosis modulators that interact with the huntington's disease gene |
| 03/14/2001 | EP1082335A1 Novel secreted and membrane-associated proteins and uses therefor |
| 03/14/2001 | EP1082334A1 Alg-2lp, alg-2 like molecules and uses therefor |
| 03/14/2001 | EP1082321A1 Heterocyclic derivatives which inhibit factor xa |
| 03/14/2001 | EP1082320A1 Novel substituted imidazole compounds |
| 03/14/2001 | EP1082315A1 Potassium channel inhibitors |
| 03/14/2001 | EP1082314A1 New dipeptidyl peptidase iv effectors |
| 03/14/2001 | EP1082308A1 Heterocyclically substituted amides used as calpain inhibitors |
| 03/14/2001 | EP1082306A1 Conformationally constrained amino acid compounds having affinity for the alpha2delta subunit of a calcium channel |
| 03/14/2001 | EP1082305A1 Pyrrole substituted 2-indolinone protein kinase inhibitors |
| 03/14/2001 | EP1082303A1 Heterocyclic derivatives which inhibit factor xa |
| 03/14/2001 | EP1082302A1 A vla-4 inhibitor: omepupa-v |
| 03/14/2001 | EP1082298A2 1$g(a)-HYDROXY-25-ENE-VITAMIN D, ANALOGS AND USES THEREOF |
| 03/14/2001 | EP1082294A1 Phenylalanine derivatives as integrin inhibitors |
| 03/14/2001 | EP1082293A2 Formoterol polymorphs |
| 03/14/2001 | EP1082289A1 Methods for identifying novel multimeric agents that modulate receptors |
| 03/14/2001 | EP1082142A2 Compositions and methods for delivery of genetic material for altering neuronal growth, regeneration, and survival |
| 03/14/2001 | EP1082139A2 CARRIER FOR $i(IN VIVO) DELIVERY OF A THERAPEUTIC AGENT |
| 03/14/2001 | EP1082138A1 Texaphyrin conjugates and uses thereof |
| 03/14/2001 | EP1082133A2 Pharmaceutical formulations for igf/igfbp |
| 03/14/2001 | EP1082128A1 Lysine containing peptides for treatment of heart disease |
| 03/14/2001 | EP1082127A1 SUCCINAMIDE INHIBITORS OF INTERLEUKIN-1$g(b) CONVERTING ENZYME |
| 03/14/2001 | EP1082119A1 Microemulsion preconcentrates containing a piperidine substance p antagonist |
| 03/14/2001 | EP1082117A1 A stabilized antihistamine syrup containing aminopolycarboxylic acid as stabilizer |
| 03/14/2001 | EP1082116A1 Use of 4-piperidinemethanol derivatives in treatment of neurodevelopmental disorders |
| 03/14/2001 | EP1082114A1 Hydroxyomeprazole compositions and uses |
| 03/14/2001 | EP1082113A2 Compositions and methods for alleviating impaired mental function, memory loss and reducing recovery time in anaesthetized mammals |
| 03/14/2001 | EP1082112A1 Endogenous nitric oxide synthesis under conditions of low oxygen tension |
| 03/14/2001 | EP1082111A1 Assay for identification of compounds that promote melanin production and retinoid-like compounds identified by said assay |
| 03/14/2001 | EP1082110A1 Use of compounds for the elevation of pyruvate dehydrogenase activity |
| 03/14/2001 | EP1082103A1 Spill resistant pharmaceutical compositions |
| 03/14/2001 | EP1082095A1 N-oxide of heterocyclic ester, amide, thioester or ketone hair growth compositions and uses |
| 03/14/2001 | EP1005333A4 Methods and compositions for preventing and treating chronological aging in human skin |
| 03/14/2001 | EP0804601B1 Genetic therapy of tumours with an endothelium cell-specific active substance which is dependent on the cell cycle |
| 03/14/2001 | EP0682664B1 Compounds having both potent calcium antagonist and antioxidant activity and use thereof as cytoprotective agents |
| 03/14/2001 | EP0675730B1 Therapeutic combination containing interferon |
| 03/14/2001 | EP0640143B1 Senescent cell derived inhibitors of dna synthesis |
| 03/14/2001 | CN1287555A N-oxides of heterocyclic compounds with TNF and PDE IV inhibiting activity |
| 03/14/2001 | CN1287554A Novel optically active aminopentane derivative |
| 03/14/2001 | CN1287494A preventives / remedies for glaucoma |
| 03/14/2001 | CN1287489A Lipase inhibiting polymers |
| 03/14/2001 | CN1287487A Aminophenoxyacetic acid derivatives as neuroprotectants and pharmaceutical composition containing the same |
| 03/14/2001 | CN1287123A Steroid and its preparation method, medicine composition and application |
| 03/14/2001 | CN1286999A Veterinary medicine |
| 03/14/2001 | CN1063180C 5H, 10H-imidazo [1,2-a] indeno [1,2-e] pyrazin-4-one derivatives, preparation thereof, and drugs containing said derivatives |
| 03/14/2001 | CN1063176C Chromone derivative |
| 03/14/2001 | CN1063085C Health food and its producing method |
| 03/14/2001 | CN1063083C Anti-senility medicine and its preparation |
| 03/13/2001 | USRE37094 Heterocyclic substituted acylaminothiazoles, their preparation and pharmaceutical compositions containing them |
| 03/13/2001 | US6201165 Drug screening by contacting isolated cardiomyocyte having calcineurin, calcium calmodulin dependent kinase iv or ii alpha, p38, or mkk6 transgene with compound; measuring physiological parameter; and comparing to control |
| 03/13/2001 | US6201132 Inhibitors of membrane-bound serine protease; aminoacyl compounds |
| 03/13/2001 | US6201108 Antibodies which bind to mammalian transforming growth factor-beta type ii receptor; treatment of bone disorders; anticarcinogenic/antimetastasis agents |
| 03/13/2001 | US6201106 Cytokine signal regulators |
| 03/13/2001 | US6201104 Amino acid sequences of angiogenesis-inhibiting protein receptor; drug screening; isolation of angiogenesis related proteins |
| 03/13/2001 | US6201103 Peptide nucleic acid incorporating a chiral backbone |
| 03/13/2001 | US6201025 For treatment of central nervous system disorders |
| 03/13/2001 | US6201021 Pentanoic acid derivatives |
| 03/13/2001 | US6201020 Effective poly(adenosine 5'-diphospho-ribose) polymerase (parp) inhibitor for treatment of tissue damage by necrosis or apoptosis; side effect reduction |
| 03/13/2001 | US6201007 Pyrrolidinyl and pyrrolinyl ethylamine compounds as kappa agonists |
| 03/13/2001 | US6201004 Dioxino derivatives and their use as therapeutic agents |
| 03/13/2001 | US6201001 Tubulin polymerization inhibitors; anticarcinogenic agents |
| 03/13/2001 | US6200995 Pyridyloxybenzenesulfonamide derivatives; diabetes, obesity |
| 03/13/2001 | US6200993 Heterosubstituted pyridine derivatives as PDE4 inhibitors |
| 03/13/2001 | US6200991 Imidazole derivatives, preparation and therapeutic application thereof |
| 03/13/2001 | US6200985 Rapamycin derivatives |
| 03/13/2001 | US6200982 Substituted 1H-pyridinyl-2-ones as GABAA-α 2/3 ligands |
| 03/13/2001 | US6200979 Administering substituted pyrazoles and pyzazolopyrimidines for treating phobias obsessive-compulsive disorder, post-traumatic stress disorder, single episode depression, recurrent depression, dysthymia, bipolar disorders |
| 03/13/2001 | US6200978 For preventing or treating inflammatory diseases such as arthritis, psoriasis, asthma, or inflammatory bowel disease, disorders of respiratory function, gastrointestinal disorders such as functional bowel disease, as analgesics |
| 03/13/2001 | US6200975 For cognition enhancement therapy |
| 03/13/2001 | US6200960 Inhibition of proliferation of cells |
| 03/13/2001 | US6200955 Heparin binding peptides |
| 03/13/2001 | US6200803 Preventing fungal contamination in cell culture by incubating cells in cell culture medium with either antisense oligonucleotide or ribozyme complementary to messenger rna of essential yeast genes |
| 03/13/2001 | US6200777 Human p101 polynucleotides |
| 03/13/2001 | US6200775 Nucleotide sequence coding a polypeptide associated with the diagnosis and treatment of infections |
| 03/13/2001 | US6200774 Compounds |
| 03/13/2001 | US6200746 Detection of enzyme inhibitor; evaluate kinase phosphorylation in presence and absence of virus, incubate with test compound, monitor decrease in enzyme activity |
| 03/13/2001 | US6200606 Isolation of precursor cells from hematopoietic and nonhematopoietic tissues and their use in vivo bone and cartilage regeneration |
| 03/13/2001 | US6200599 Ortho ester lipids |
| 03/13/2001 | US6200569 Water extract or a dilute acidic extract of polygonum multiform roots or cinnamomum bark; decreasing the glycosylated hemoglobin level or blood glucose level in a hyperglycemic patient |
| 03/13/2001 | US6200565 Oral administration of immunoglobulins for treating autoimmune hearing loss |
| 03/13/2001 | US6200562 Method for reducing absorption of dietary oxalate using enzymes and microbes |
| 03/13/2001 | US6199554 Method and apparatus for combining injury-mediated therapy and drug delivery |
| 03/13/2001 | CA2167651C Biologically highly active bicyclic aromatic compositions; pharmaceutical and cosmetic compositions containing the same and their use |
| 03/13/2001 | CA2146238C Novel mercaptoacetylamide bicyclic lactam derivatives useful as inhibitors of enkephalinase and ace |